Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.
Front Pharmacol. 2020 May 27;11:730. doi: 10.3389/fphar.2020.00730. eCollection 2020.
Front Pharmacol. 2020.
PMID: 32536865
Free PMC article.
Review.